- Tytuł:
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
- Autorzy:
- Źródło:
- The Lancet; December 2019, Vol. 394 Issue: 10214 p2096-2107, 12p
Periodyk